SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-035827
Filing Date
2021-05-25
Accepted
2021-05-25 21:00:51
Documents
2
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1476
2 EX-24 DOCUMENT attachment1.htm EX-24 4246
  Complete submission text file 0001209191-21-035827.txt   7103
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IGNYTA, INC. 11095 FLINTKOTE AVENUE, SUITE D SAN DIEGO CA 92121
Business Address
Zaknoen Sara (Reporting) CIK: 0001602225 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37378 | Film No.: 21962486